Name | Type | Posted | Actions |
|---|---|---|---|
SPE2D221D0135 P00005.pdf | Jun 13, 2025 | ||
SPE2D2-21-D-0135 P00009.pdf | Jun 13, 2025 | ||
Option Year 1 ModIfication P00002 SPE2D2-21-D-0135.pdf | Jun 13, 2025 | ||
Mod SPE2D221D0135P00003.pdf | Jun 13, 2025 | ||
Signed. Sertraline HCL Award SPE2D221D0135.pdf | Jun 28, 2021 |
Sertraline HCL Tablets
Contact and place of performance
Keith Ryales
Hauppauge, NY 11788
USA
Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.
The Defense Logistics Agency Troop Support issued this award notice for the procurement of Sertraline HCL tablets under solicitation number SPE2D220R0067. The contract falls under NAICS code 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. The primary place of performance for this requirement is Hauppauge, New York, with Keith Ryales serving as the point of contact.
The scope of the award covers Sertraline HCL tablets in various strengths and bottle sizes, including 25MG dosages in 30, 90, 180, and 500 count bottles. The procurement also includes 50MG tablets in 30, 90, 180, and 500 count bottles, as well as additional configurations in 30, 60, 90, 180, and 500 count bottles.
The record for this award includes five PDF attachments related to contract SPE2D221D0135. These documents consist of the signed award notice, multiple contract modifications, and an Option Year 1 modification. The initial award information was published on August 10, 2020, with the most recent update occurring on June 13, 2025.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.